You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2024

CLINICAL TRIALS PROFILE FOR XALATAN

✉ Email this page to a colleague

« Back to Dashboard

505(b)(2) Clinical Trials for Xalatan

This table shows clinical trials for potential 505(b)(2) applications. See the next table for all clinical trials

Subscribe to access the full database, or Subscribe
Trial Type	Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
OTC	NCT00402493 ↗	Study to Determine if Taking OTC Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Glaucoma Drops	Completed	Pfizer	N/A	2006-12-01	The Purpose of This Study is to Determine if Taking an Over the Counter Non-Steroidal Anti-Inflammatory(Ibuprofen)has an Effect on Eye Pressure in Patients using Brimonidine(Alphagan)and Latanoprost(Xalatan) eye drops.
OTC	NCT00402493 ↗	Study to Determine if Taking OTC Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Glaucoma Drops	Completed	Philadelphia Eye Associates	N/A	2006-12-01	The Purpose of This Study is to Determine if Taking an Over the Counter Non-Steroidal Anti-Inflammatory(Ibuprofen)has an Effect on Eye Pressure in Patients using Brimonidine(Alphagan)and Latanoprost(Xalatan) eye drops.
>Trial Type	>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

All Clinical Trials for Xalatan

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00140062 ↗	Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension.	Completed	Pfizer	Phase 4	2002-02-01	The primary purpose is to compare the intraocular pressure reducing effect of Xalatan with that of usual care over 36 months. Safety and health care utilization will be evaluated.
NCT00143429 ↗	Corneal Versus Conjunctival Delivery Using a Delivery Device	Withdrawn	Pfizer	Phase 2	1969-12-31	Compare the antihypertensive efficacy of three methods for installing Xalatan
NCT00143429 ↗	Corneal Versus Conjunctival Delivery Using a Delivery Device	Withdrawn	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 2	1969-12-31	Compare the antihypertensive efficacy of three methods for installing Xalatan
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Xalatan

Condition Name

Chart
Table

Condition Name for Xalatan
Intervention	Trials
Ocular Hypertension	44
Glaucoma	27
Open-Angle Glaucoma	17
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Xalatan
Intervention	Trials
Glaucoma	67
Ocular Hypertension	51
Hypertension	43
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Xalatan

Trials by Country

Map
Table

Trials by Country for Xalatan
Location	Trials
United States	123
Canada	15
Japan	13
France	4
Finland	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Xalatan
Location	Trials
Texas	9
Florida	9
California	8
Tennessee	6
New York	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Xalatan

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Xalatan
Clinical Trial Phase	Trials
Phase 4	33
Phase 3	16
Phase 2	11
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Xalatan
Clinical Trial Phase	Trials
Completed	58
Unknown status	9
Terminated	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Xalatan

Sponsor Name

Chart
Table

Sponsor Name for Xalatan
Sponsor	Trials
Pfizer	19
Alcon Research	15
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	10
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Xalatan
Sponsor	Trials
Industry	68
Other	38
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.